BioCentury
ARTICLE | Company News

Lilly, Lupin in diabetes deal for India, Nepal

August 3, 2011 12:12 AM UTC

Eli Lilly and Co. (NYSE:LLY) partnered with Lupin Ltd. (NSE:LUPIN; BSE:500257) to promote and distribute Lilly's Huminsulin diabetes products in India and Nepal. Details were not disclosed. ...